Protocol for the specified clinical experience investigation on the single use of Casodex Tablet 80 mg

Study identifier:CAMON

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Other

Official Title

Protocol for the specified clinical experience investigation on the single use of Casodex Tablet 80 mg

Medical condition

prostate cancer

Phase

N/A

Healthy volunteers

-

Study drug

-

Sex

-

Actual enrollment

-

Study type

Interventional

Age

-

Date

Study Start Date: 01 May 2009
Primary Completion Date: -
Study Completion Date: -

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

-

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria